1 The findings showed: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) As a retrospective analysis, this study has limitations including potential confounding factors, and definitive randomised controlled trials are needed to confirm any disease-modifying effects of GLP-1 medications in MS
Why Genetic Testing Matters Before Choosing Your Weight Loss Protocol The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Among the many types of post-translational modifications (PTMs), phosphorylation modification is present in approximately one-third of all proteins and ranks as one of the most prevalent and significant types of modifications
Ideal Wegovy candidates should also possess at least one health condition related to weight
Another benefit of saffron supplementation is improved objective sleep quality
As a result, many patients pay out of pocket to access these drugs for weight loss